ArticleHaematologica2024

Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies.

Markus Perl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.